Cancer Screening Frequency: How Often Should You Get Checked?

Cancer screening schedules are designed to catch disease early—when treatment is most effective. But the frequency of these screenings varies depending on age, gender, personal risk, and family history. Following the right schedule ensures timely detection while avoiding unnecessary procedures.

Knowing when to start, how often to repeat, and when to stop specific screenings is essential for preventive care. These guidelines are typically set by organizations like the U.S. Preventive Services Task Force and updated based on evolving medical research.

Breast cancer screening

Mammograms are the most common screening test for breast cancer. The frequency depends on age and personal risk.

Women aged 40 to 49: Discuss with a healthcare provider; some start annual screenings at 40 based on risk factors
Women aged 50 to 74: Mammogram every 2 years for average-risk individuals
Women with higher risk (family history or BRCA mutation): May begin annual screenings earlier, often including breast MRI

The decision to continue screening after age 75 depends on individual health status and life expectancy.

Cervical cancer screening

Cervical cancer screening is recommended for most individuals with a cervix starting at age 21.

Ages 21 to 29: Pap test every 3 years
Ages 30 to 65: Pap test every 3 years, or HPV test every 5 years, or a combination of both every 5 years
Over age 65: May stop screening if prior results have been consistently normal and there is no history of cervical disease

Individuals who have had a total hysterectomy for non-cancerous reasons may not need further screening.

Colorectal cancer screening

Colorectal cancer screening generally begins at age 45 for average-risk adults.

Colonoscopy every 10 years is the gold standard
Alternative options include stool-based tests (annually or every 3 years depending on the test type), or CT colonography every 5 years
Individuals with a family history or personal history of polyps may need earlier or more frequent screening

Screening typically continues until age 75. For those between 76 and 85, the decision depends on overall health and screening history.

Prostate cancer screening

Prostate cancer screening involves a PSA (prostate-specific antigen) blood test, sometimes combined with a digital rectal exam.

Men aged 50 to 69: Decision to screen should be individualized after a discussion about risks and benefits
Men at higher risk (African American men, those with a family history): May start screening around age 45
Over age 70: Screening is generally not recommended unless health status indicates otherwise

The interval between screenings may vary depending on PSA levels and previous results.

Lung cancer screening

Lung cancer screening is recommended for individuals at high risk due to smoking history.

Adults aged 50 to 80 with a 20 pack-year smoking history (currently smoking or quit within the past 15 years): Annual low-dose CT scan
Screening should stop when the person has not smoked for 15 years or develops health problems that limit life expectancy or the ability to undergo treatment

This screening is not recommended for non-smokers or those at low risk.

Skin cancer screening

Routine skin cancer screenings are not universally recommended for the general population, but regular self-checks and clinical exams may be advised for those at increased risk.

People with fair skin, a history of sunburns, multiple moles, or a family history of melanoma may benefit from yearly skin checks by a dermatologist
Any new, changing, or unusual spots should be evaluated promptly, regardless of formal screening intervals

There is no standardized interval for population-wide screening, but individualized monitoring is key.

Ovarian and pancreatic cancer

Routine screening for ovarian and pancreatic cancer is not recommended for average-risk individuals due to the lack of reliable, widely accepted tests.

Those with known genetic syndromes or strong family history may undergo periodic blood tests or imaging based on provider recommendations
Screening intervals in these high-risk groups vary depending on the specific genetic condition and clinical findings

These screenings are highly personalized and often conducted as part of a specialized surveillance program.

General screening considerations

Cancer screening frequency should always be tailored to the individual. Factors that influence screening schedules include:

Family history of cancer
Known genetic mutations
Lifestyle risk factors (smoking, obesity, alcohol use)
Personal history of cancer or polyps
Age, sex, and race-related risks

Screening guidelines may change as more research becomes available, so it’s important to revisit these discussions during routine checkups.

Takeaway

Cancer screenings are most effective when performed at the right time and at the right intervals. Sticking to a schedule based on individual risk helps ensure early detection without overtesting. Regular conversations with healthcare providers support a proactive approach to long-term cancer prevention and monitoring.